Sangamo ties up with a newcomer in the cell therapy field; LabCorp wins FDA authorization of latest Covid-19 test
→ A year after its launch, upstart cell conversion biotech Mogrify has inked a collaboration deal with Sangamo, which plans …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
